BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36303977)

  • 1. Use of Moisturizers and Lubricants for Vulvovaginal Atrophy.
    Sarmento ACA; Kamilos MF; Costa APF; Vieira-Baptista P; Eleutério J; Gonçalves AK
    Front Reprod Health; 2021; 3():781353. PubMed ID: 36303977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Genitourinary Syndrome of Menopause: An Overview of the Recent Data.
    Angelou K; Grigoriadis T; Diakosavvas M; Zacharakis D; Athanasiou S
    Cureus; 2020 Apr; 12(4):e7586. PubMed ID: 32399320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview.
    Sinha A; Ewies AA
    Climacteric; 2013 Jun; 16(3):305-12. PubMed ID: 23215675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genitourinary menopause syndrome. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
    Hocké C; Diaz M; Bernard V; Frantz S; Lambert M; Mathieu C; Grellety-Cherbero M
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):394-413. PubMed ID: 33757926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
    Edwards D; Panay N
    Climacteric; 2016 Apr; 19(2):151-61. PubMed ID: 26707589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety.
    Potter N; Panay N
    Climacteric; 2021 Feb; 24(1):19-24. PubMed ID: 32990054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the genitourinary syndrome of menopause.
    Palacios S; Mejía A; Neyro JL
    Climacteric; 2015; 18 Suppl 1():23-9. PubMed ID: 26366797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update.
    Merlino L; D'Ovidio G; Matys V; Piccioni MG; Porpora MG; Senatori R; Viscardi MF; Vitale A; Della Rocca C; On Behalf Of Policlinico Umberto I Collaborators
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.
    Crean-Tate KK; Faubion SS; Pederson HJ; Vencill JA; Batur P
    Am J Obstet Gynecol; 2020 Feb; 222(2):103-113. PubMed ID: 31473229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genitourinary Syndrome of Menopause.
    Shifren JL
    Clin Obstet Gynecol; 2018 Sep; 61(3):508-516. PubMed ID: 29787390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.
    Menopause; 2013 Sep; 20(9):888-902; quiz 903-4. PubMed ID: 23985562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of genitourinary syndrome of menopause in breast cancer survivors: An update.
    Lubián López DM
    World J Clin Oncol; 2022 Feb; 13(2):71-100. PubMed ID: 35316932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's new in the world of postmenopausal sex?
    Iglesia CB
    Curr Opin Obstet Gynecol; 2016 Oct; 28(5):449-54. PubMed ID: 27517339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease.
    Pérez-López FR; Phillips N; Vieira-Baptista P; Cohen-Sacher B; Fialho SCAV; Stockdale CK
    Gynecol Endocrinol; 2021 Aug; 37(8):746-752. PubMed ID: 34169794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
    Rahn DD; Carberry C; Sanses TV; Mamik MM; Ward RM; Meriwether KV; Olivera CK; Abed H; Balk EM; Murphy M;
    Obstet Gynecol; 2014 Dec; 124(6):1147-1156. PubMed ID: 25415166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment options for postmenopausal vaginal atrophy.
    Naumova I; Castelo-Branco C
    Int J Womens Health; 2018; 10():387-395. PubMed ID: 30104904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal estrogens for the treatment of dyspareunia.
    Krychman ML
    J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local estrogen therapy--clinical implications--2012 update].
    Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.
    The NAMS 2020 GSM Position Statement Editorial Panel
    Menopause; 2020 Sep; 27(9):976-992. PubMed ID: 32852449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal Health During Breast Cancer Treatment.
    Falk SJ; Bober S
    Curr Oncol Rep; 2016 May; 18(5):32. PubMed ID: 27074843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.